Rapid Acting Antidepressants: Advances in Pharmacology, cartea 89
Ronald S. Duman, John H. Krystalen Limba Engleză Hardback – 26 iun 2020
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Din seria Advances in Pharmacology
- 29%
Preț: 1291.74 lei - 29%
Preț: 1099.26 lei - 29%
Preț: 1099.26 lei - 33%
Preț: 1099.26 lei - 33%
Preț: 1099.26 lei - 27%
Preț: 946.81 lei - 5%
Preț: 1236.44 lei - 5%
Preț: 438.32 lei - 27%
Preț: 946.55 lei - 5%
Preț: 400.40 lei - 5%
Preț: 1231.57 lei - 32%
Preț: 1033.18 lei - 33%
Preț: 1163.39 lei - 33%
Preț: 1103.94 lei - 32%
Preț: 1109.69 lei - 35%
Preț: 1055.70 lei - 35%
Preț: 1061.89 lei - 32%
Preț: 1106.27 lei - 35%
Preț: 1060.12 lei - 9%
Preț: 1061.89 lei - 33%
Preț: 1103.42 lei - 32%
Preț: 1108.97 lei - 33%
Preț: 1104.52 lei - 33%
Preț: 1103.68 lei - 29%
Preț: 1101.18 lei - 33%
Preț: 1101.45 lei - 33%
Preț: 1102.19 lei - 28%
Preț: 1183.07 lei - 28%
Preț: 1182.15 lei - 29%
Preț: 1102.47 lei - 20%
Preț: 1244.00 lei - 19%
Preț: 1250.10 lei - 29%
Preț: 1105.92 lei - 29%
Preț: 1104.88 lei - 29%
Preț: 1105.34 lei - 29%
Preț: 1103.87 lei - 28%
Preț: 1107.54 lei - 29%
Preț: 1102.55 lei - 29%
Preț: 1105.16 lei
Preț: 1184.19 lei
Preț vechi: 1816.83 lei
-35%
Puncte Express: 1776
Preț estimativ în valută:
209.62€ • 243.48$ • 181.60£
209.62€ • 243.48$ • 181.60£
Carte tipărită la comandă
Livrare economică 23 februarie-09 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128201893
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
ISBN-10: 0128201894
Pagini: 402
Dimensiuni: 152 x 229 mm
Greutate: 0.71 kg
Editura: ELSEVIER SCIENCE
Seria Advances in Pharmacology
Public țintă
investigators in neuroscience, pharmacology, neurology, psychiatry, medicine.Cuprins
Part I – Neurobiology of ketamine effects
- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmissionAllie J. Widman and Lori L. McMahon
- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibitionBernhard Luscher, Mengyang Feng and Sarah J. Jefferson
- The role of eEF2 kinase in the rapid antidepressant actions of ketamineKanzo Suzuki and Lisa M. Monteggia
Part II – The rapid therapeutic effects of ketamine - Clinical overview of NMDA-R antagonists and clinical practicePasha A. Davoudian and Samuel T. Wilkinson
- Ketamine for depression clinical issuesSyed Z. Iqbal and Sanjay J. Mathew
- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidenceLynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
- Neurobiological biomarkers of response to ketamineBashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressantsJaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
- The emergence of ketamine as a novel treatment for posttraumatic stress disorderAdriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney
Part III – Novel rapid-acting antidepressant mechanisms related to ketamine - mGlu2/3 receptor as a novel target for rapid acting antidepressantsShigeyuki Chaki
- Involvement of muscarinic receptor mechanisms in antidepressant drug actionJeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions